Table 1 Patient demographics
Number | Percent | |
|---|---|---|
Gender | ||
Males | 98 | 64.5% |
Females | 54 | 35.5% |
Admission Diagnosis | ||
Infection | 28 | 18.4% |
Hyponatraemia | 22 | 14.5% |
Elective Admission | 15 | 9.9% |
Cancer or cancer related complication | 15 | 9.9% |
Chronic liver disease | 9 | 5.9% |
Acute Coronary Syndrome or Arrhythmia | 9 | 5.9% |
Fall | 8 | 5.3% |
Fracture | 7 | 4.6% |
Congestive heart failure | 6 | 3.9% |
Intracerebral haemorrhage / CVA | 6 | 3.9% |
Psychiatric condition | 3 | 2.0% |
Other | 24 | 15.8% |
Comorbid conditions | ||
Chronic kidney disease | 30 | 19.7% |
Congestive heart failure | 22 | 14.5% |
Chronic liver disease | 22 | 14.5% |
Contributing Medication on admission | ||
Angiotensin II Receptor blocker | 25 | 16.4% |
ACE inhibitor | 24 | 15.8% |
Antidepressant | 18 | 11.8% |
Anticonvulsant | 13 | 8.6% |
Antipsychotic | 11 | 7.2% |
Pregabalin | 6 | 3.9% |
Diuretic Use on Admission | ||
Frusemide | 31 | 20.4% |
Spironolactone | 15 | 9.9% |
Thiazide | 9 | 5.9% |
Indapamide | 1 | 0.7% |
Duration of Hyponatraemia | ||
Chronic (> 48 h duration) | 77 | 50.7% |
Acute | 10 | 6.6% |
Unknown | 65 | 42.8% |
Symptoms of Hyponatraemia | ||
None | 106 | 69.7% |
Nausea/vomiting | 21 | 13.8% |
Lethargy | 11 | 7.2% |
Confusion | 9 | 5.9% |
Decreased level of consciousness | 5 | 3.3% |
Seizure | 2 | 1.3% |